Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-23-000168

General Counsel sold 3,000 shares at $7.04 ($21,120)

From the SEC's structured data for this filing

Trades in this filing

Bhavnagri Veer · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Sale : show line 1 in the form −3,000 $7.04 $21,120 580,677 D
Open-market sales · 3,000 sh · avg $7.04 · $21,120
Loading xslF345X03/primary_01.xml…